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Objectives: To evaluate general practitioners’ (GPs’)
prescribing behaviour as a determinant of persistence
with and adherence to inhaled corticosteroids (ICS) in
children.
Design: Prospective observational study of persistence
with and adherence to ICS followed by a focus group
study of the GPs prescribing this treatment.
Setting: 7 primary care practices in the area of Zwolle,
the Netherlands.
Participants: 134 children aged 2–12 years had been
prescribed ICS in the year before the study started by
their 19 GPs.
Main outcome measures: Patterns and motives of
GPs’ prescribing behaviour and the relationship with
persistence with and adherence to ICS.
Results: GPs’ prescribing behaviour was characterised
by prescribing short courses of ICS to children with
various respiratory symptoms without follow-up for
making a diagnosis of asthma. This was driven by the
GPs’ pragmatic approach to deal with the large number
of children with respiratory symptoms, and by beliefs
about ICS which differed from currently available
evidence. This prescribing behaviour was the main
reason why 68 (51%) children did not persist with the
use of ICS. In children with persistent use of ICS and a
GP’s advice to use ICS on a daily basis, the median
(IQR) adherence was 70% (41–84%), and was similar
for patients with persistent asthma and children lacking
a diagnosis or symptoms of asthma.
Conclusions: Inappropriate prescription of ICS to
children by GPs is common and drives the lack of
persistence with ICS therapy in primary care. This
finding should be taken into account when interpreting
data from large prescription database studies.
Improving primary healthcare providers’ knowledge and
competence in diagnosing and managing asthma in
children is needed.
INTRODUCTION
Childhood asthma guidelines are unanimous
in recommending daily inhaled corticoster-
oids (ICS) maintenance treatment only for
children with persistent asthma.1–3 Maximal
efﬁcacy of such treatment can only be
achieved by high adherence rates above 80%
of prescribed dosages and by persistence
with this therapy over long periods.4 To
ARTICLE SUMMARY
Article focus
▪ Persistence with inhaled corticosteroids (ICS) in
children is poor, and patients and parents are
usually held responsible.
▪ Physician’s prescribing behaviour has received
little attention in the literature to date as a deter-
minant of poor persistence with ICS.
▪ We evaluated general practitioners’ (GPs’) pre-
scribing behaviour as a determinant of persist-
ence with and adherence to ICS in children.
Key messages
▪ GPs’ prescribing behaviour was characterised by
prescribing short courses of ICS to children with
various respiratory symptoms without follow-up
and without diagnosing asthma.
▪ This was driven by the GPs’ pragmatic approach
to deal with the large number of children with
respiratory symptoms, and by beliefs about ICS
which differed from currently available evidence.
▪ The very low persistence with ICS in children is
largely explained by this prescribing behaviour.
Strengths and limitations of this study
▪ By collecting detailed information about the
patients’ symptoms and ICS use, and on the
reasons and motivations for GPs’ prescribing
behaviour, a novel explanation for the previously
described poor ICS persistence in children was
provided.
▪ The generalisability of this study may be limited
because we studied only the GPs willing to par-
ticipate in the study, but we found several simi-
larities of our findings with previous reports of
prescribing patterns of ICS in primary care in
several countries.
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ensure this, close follow-up of children with asthma is
recommended.1–3
In daily practice, however, both persistence with ICS
prescriptions and adherence to their daily use is usually
poor. Only half of the children having received a ﬁrst pre-
scription of ICS have an ongoing prescription 1 year later
(poor persistence), and adherence rates to daily ICS use
range from 30% to 70% in different studies.5–7 Patients
and their parents are usually held responsible for the
poor persistence and adherence to ICS treatment,8 9 and
interventions to enhance medication adherence are
focused on how healthcare providers can improve
patients’ and their parents’ adherence behaviour.10
In disagreement with childhood asthma management
guidelines, most children with asthma are not being fol-
lowed up regularly in primary care,11 12 and many children
with an ICS prescription have not been diagnosed with per-
sistent asthma.7 13 Although these observations suggest that
physician’s prescribing behaviour and primary healthcare
organisation issues also may be important in determining
poor persistence with and adherence to ICS treatment in
children with asthma, this has received little attention in
the literature to date. In particular, the reasons why
primary care physicians choose to deviate from their child-
hood asthma management guideline have not been
explored to our knowledge. We designed this study to
evaluate primary healthcare providers’ prescribing behav-
iour, both quantitatively and qualitatively, and the role of
this behaviour in persistence with and adherence to ICS
prescriptions in children with asthma in primary care.
METHODS
This was a sequential mixed-methods study, starting with
a quantitative study on ICS prescriptions and adherence
to ICS use in children 2–12 years of age in primary care,
followed by a qualitative study in which general practi-
tioners (GPs) were interviewed about the motivation
underlying their prescription patterns.
Participating GPs
Nineteen GPs in the catchment area of our hospital,
both from rural and urban regions’ primary care prac-
tices, were willing to participate in the study. GPs who
had participated in a previous study from our clinic were
approached, after which these GPs recruited colleagues.
The mean age of the participating GPs was 50 years
(range 35–65 years), and they had been in practice for a
mean of 15 years. There were 16 men (84%); most GPs
(16, 84%) worked in group practices. The six GPs ini-
tially approached because of their previous participation
in a study were known for their interest in childhood
asthma care, the other GPs did not follow speciﬁc
courses on the management of childhood asthma.
Inclusion of children
The quantitative part of our study was a 12-month longi-
tudinal study in which adherence was measured
electronically in children with persistent ICS use. GPs
provided details of all 2-year-old to 12-year-old children
who had received an ICS prescription in the last
12 months. These children were eligible for inclusion in
our study. We excluded children who had been referred
to secondary care for respiratory symptoms, those with
severe comorbidity, and children whose parents had
insufﬁcient knowledge of the Dutch language. We
approached not more than 20 children per GP to
prevent over-reliance of study results on GPs with high
ICS prescription rates, and included only one child per
family. Patients who had not used ICS and had had no
asthma symptoms in the last 6 months, and patients with
occasional intermittent ICS use (less than 2 weeks/year)
were excluded from the 12-month longitudinal study.
Interviews with parents
To obtain a cross-sectional assessment of ICS prescrip-
tion patterns in primary care, parents who agreed to par-
ticipate were interviewed in a structured fashion about
respiratory symptoms, ICS use and bronchodilator use of
their child in the past 12 months.
Assessing adherence
In patients with persistent use of ICS by metered dose
inhaler (MDI)/spacer combination or dry powder inhaler
(DPI), adherence was monitored during the 12-month
longitudinal follow-up study by the Smartinhaler (MDI) or
the SmartDisk (DPI), electronic devices logging date and
time of each ICS actuation.14 15 Patients were excluded
from adherence analysis if their ICS were withdrawn and
stopped within 3 months of entry into the longitudinal
follow-up study. In all other patients, adherence was calcu-
lated as the number of Smartinhaler-recorded or
SmartDisk-recorded inhaled doses expressed as a percent-
age of the number of doses prescribed, and censored at
100% of the prescribed dose.15 At the end of the 1-year
follow-up study, respiratory symptoms were recorded by
validated questionnaire,16 supplemented with parental
information about doctor’s prescription of ICS and
bronchodilators, and about the GP’s advice on how to use
these medications. Data on follow-up visits and organisa-
tion of asthma care were obtained by chart review.
Interviews with GPs
After completing the 1-year follow-up in all the patients,
the aggregated adherence results and data on follow-up
and organisation of asthma care were discussed in a
2.5 h focus group interview to which all participating
GPs were invited, eight of whom (representing all
primary practices involved in the study, mean age
54 years, range 39–65 years) participated. Patterns of
prescription of asthma medication to children and
deviations from the primary care childhood asthma prac-
tice guideline were discussed. Reasons and motives for
this behaviour were explored in a non-judgmental
manner, along with a discussion of perceived advantages
and drawbacks of the GPs’ prescribing behaviour. This
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interview was audio recorded and analysed using stand-
ard methods of qualitative studies, as in earlier work
from our group.17 At the end of the focus group inter-
view, a theoretical framework of the views discussed was
developed by the senior researcher based on a recapitu-
lation of the main ﬁndings, which was discussed and
modiﬁed through discussion with all participating GP’s
until everyone present agreed with the ﬁnal framework.
The transcript was charted according to this theoretical
framework, focused on detection of quotations not sup-
porting the original framework or providing new cat-
egories or themes. The ﬁve themes that emerged from
the date comprised: ‘bridging a period of symptoms’,
‘difﬁculties in establishing a diagnosis of asthma’,
‘a pragmatical way of working’, ‘organisational issues’
and ‘perceptions about asthma and ICS’. The ﬁnal inter-
pretation of the data and the analysis of their possible
explanations were checked by one of the attending GPs.
Ethical considerations
This study was approved by the hospital ethics review
board; all the parents provided written informed consent.
RESULTS
Patients
Patient recruitment is presented in ﬁgure 1. The 19 GPs
had a mean of 11 (range 3–28) patients between 2 and
12 years of age who had received a prescription of ICS
in the last year, had no severe comorbidity and had
never been referred to secondary care. Of the 165 eli-
gible children, parents of 12 children could not be
reached by telephone and 19 declined participation,
leaving a total of 134 children whose parents provided
information about ICS use. Only 66 of these children
(49%) fulﬁlled the criteria of persistent ICS use. Their
adherence to ICS maintenance therapy was measured
electronically for 1 year. During this period, seven chil-
dren were lost to follow-up (ﬁgure 1).
Result of interviews with parents of children being
prescribed ICS
Of the 134 patients (median age 5.7, IQR 4–9.8 years)
whose parents were interviewed, ICS were stopped com-
pletely or used for less than 2 weeks/year in 68 (51%).
Parents of 43 (63%) of these patients with non-persistence
with ICS reported that they had been using ICS in short
courses at the GP’s advice, and 14 of these parents (21%)
reported that their child had been using only one single
course of ICS ever (table 1). Parents of 21 children (31%)
reported chronic cough as the main symptom of their
child; 18 parents (26%) reported that their child had
never been prescribed a bronchodilator. Three children
had been using ICS for episodes of croup.
Symptoms and medication use during 1 year follow-up
Of the 59 children (median age 7.3, IQR 5–10.8 years)
completing the 1-year adherence monitoring period, 26
(45%) never received a diagnosis of asthma according to
the parents (table 2). Based on parental report and
chart review, 15 (26%) and 11 patients (19%) had never
wheezed or suffered from breathlessness, respectively,
and parents of 10 patients (17%) reported that ICS had
been prescribed for persistent cough. During the 1-year
follow-up period, 13 children (22%) remained com-
pletely free from wheezing or breathlessness.
Bronchodilators had never been prescribed to six
patients (10%); eight others (14%) had been recom-
mended to use their bronchodilator on a daily basis
(table 2). Although older children more frequently had
a diagnosis of asthma (56% vs 21%, p=0.008) and were
more often advised to use ICS regularly (78% vs 43%,
p=0.001), differences between age groups in reported
symptoms supporting an asthma diagnosis or the fre-
quency of such symptoms were small (all p values >0.1,
table 2).
Determinants of adherence during 1 year follow-up
During the 1-year follow-up, electronic adherence mea-
surements were collected for a median (IQR) of 238
(121–350) days. Missing days were caused by children
stopping ICS at their GP’s advice during a ‘good’ season
with little symptoms, children in whom ICS therapy was
stopped altogether because of clinical remission and by
technical device failures. Parents of 13 patients reported
that their GP had recommended using ICS episodically
when the child was symptomatic, but parents of 4 of
these children administered ICS to their child for more
than 50% of days.
In the 46 children who were prescribed long-term
daily ICS, the median (IQR) adherence rate was 70%
(41–84%); 32 children (70%) had adherence rates
below 80%. Adherence was not determined by the pres-
ence of symptoms supporting an asthma diagnosis or by
frequency of symptoms (table 2).
Focus group interview with GPs
All GPs recognised the poor persistence with ICS and
intermittent use of ICS as representative patterns of
their prescription behaviour. As a general rule, they
would prescribe a short ICS course to children with
respiratory symptoms ranging from obvious wheezing
and breathlessness to mild wheezing or persistent
cough. Prescription of ICS in this way was accompanied
by instruction to parents to return with their child after
6 weeks if symptoms persisted (which rarely occurred),
or to stop ICS if symptoms resolved. GPs explained this
prescription behaviour as a practical strategy to manage
children with a range of respiratory symptoms without
having to focus on making or excluding speciﬁc
diagnoses.
GP 3: It is not a conscious process; it is determined by
the way we work.
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For children with symptoms likely to be self-limiting,
such as chronic cough, the main reason for ICS pre-
scription was to ‘bridge a period with symptoms’. In par-
ticular when parents were expecting or demanding a
therapy, this strategy was used. In the GP’s opinion, this
satisﬁed parents and prevented lengthy discussions
about the lack of effective treatment options for cough,
and about the need for referral to secondary care.
GP 4: Parents and children are satisﬁed, that’s great. The
diagnosis doesn’t really matter.
GP 1: I sometimes think back to the good old days when
we were still allowed to use oral anticholinergics to help
bridge a period of symptoms.
If symptoms returned in children with more obvious
wheezing disorders, parents were encouraged to start
another short ICS course themselves or the GP would
prescribe it once again. Although GPs realised that they
did not follow-up these patients or evaluated treatment
effect, many considered these repeated ICS bursts as
serial ‘treatment trials’, building up to an eventual
asthma diagnosis in some children. Most GPs expressed
lack of conﬁdence in their ability to diagnose asthma,
particularly in young children.
GP 8: It is symptom treatment, really. On and off, you
know, without thinking about a diagnosis.
Figure 1 Inclusion of patients.
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GP 5: A diagnosis of asthma is rarely made by me; I guess
this happens mainly in secondary care. They have better
diagnostic tools there, like lung function.
Besides the two main reasons for prescribing short
courses of ICS (bridging a period of symptoms and
working on establishing a diagnosis of asthma), GPs
expressed additional perceptions about ICS and asthma
that supported their prescribing behaviour. Most GPs
viewed a 6-week course of ICS as an effective treatment
option for children with chronic cough or intermittent
wheezing. For some GPs this view was driven by their
perception that these symptoms could be presenting
symptoms of asthma.
GP 6: Cough is also an expression of inﬂammation,
which ICS may help to control.
This prescribing behaviour was also driven by the GPs’
desire not to undertreat asthma. In their opinion the
pros of this approach (not undertreating asthma) out-
weighed the cons (overtreatment of non-speciﬁc cough
and mild intermittent wheezing with ICS), because they
viewed short ICS courses as harmless. They remarked
that the reactive organisation of primary healthcare for
children (ie, seeing the child only when symptoms
occurred) instead of being proactive (with scheduled
follow-up) enhanced this prescribing behaviour.
GP 3: Most important lesson of this study for me?
Making asthma care more proactive!
DISCUSSION
This study shows a common practice of prescribing short
courses of ICS to children with various respiratory symp-
toms in primary care. This prescribing behaviour, which
deviates from primary care childhood asthma manage-
ment guidelines, is driven by a pragmatic approach
aimed at symptom treatment rather than making or
excluding the diagnosis of asthma, and is enhanced by




4 years of age
(n=14)
Median adherence for
children advised to use ICS
on a daily basis (IQR)




13 (22%) 8 (57%) Not calculated
Symptoms not supporting asthma
diagnosis
Never wheezing 15 (25%) 4 (28%) 70% (31–82%)
Never breathlessness 11 (19%) 3 (21%) 66% (53–81%)
ICS as treatment for
persistent cough
10 (17%) 5 (36%) 71% (60–85%)
No GP diagnosis of asthma 26 (44%) 11 (79%) 67% (22–85%)
Frequency of wheezing/




13 (22%) 5 (36%) 61% (54–87%)
This year 1–3 periods
with symptoms
25 (42%) 5 (36%) 70% (30–81%)
This year >3 periods
with symptoms
21 (36%) 4 (28%) 73% (26–87%)
Use of bronchodilator Used daily 8 (14%) 1 (7%) 76% (52–87%)
Never prescribed,
never used
6 (10%) 4 (28%) 77% (70–86%)
GP’s advice, general practitioner’s advice; ICS, inhaled corticosteroids.






Use of ICS only in periods with symptoms (as prescribed by GP, for various
respiratory symptoms), >6 months no symptoms
43 (32%) 24 (51%)
Short course of ICS once in first wheezing episode 14 (11%) 6 (13%)
Daily use of ICS stopped at GP’s advice because of remission of symptoms 11 (8%) 6 (13%)
Persistent use
Persistent use in children 66 (49%) 11 (23%)
GP, general practitioner; ICS, inhaled corticosteroids.
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the reactive organisation of primary care, where children
are mainly being seen when symptoms occur, instead of
being followed up regularly. Many GPs expressed per-
ceptions about ICS and asthma which are in disagree-
ment with the currently available evidence, stimulating
the overtreatment of children with non-speciﬁc or mild
intermittent respiratory symptoms. The very low persist-
ence with ICS in children is largely explained by this
prescribing behaviour. Of the 59 children with persistent
use of ICS, 20% used ICS only during symptomatic epi-
sodes (at the GP’s advice) and a similar proportion had
no asthmatic symptoms ever but used ICS on a daily
basis. Children with persistent wheeze were also com-
monly treated with intermittent courses of ICS.
The high ICS prescription rates in children without
persistent asthma and low persistence with ICS that we
found conﬁrm results from previous studies in various
countries. In two Dutch primary care studies, ICS were
frequently prescribed to children and adults without a
diagnosis of persistent asthma, and ICS persistence over
a 1-year follow-up period was only 50%.7 18 In a large
Dutch birth cohort study, 36% of children 2–8 years of
age used ICS without having reported a single episode
of wheezing in the past 2 years.19 Several UK studies also
reported high ICS prescription rates in children without
persistent asthma, but with intermittent wheeze or
chronic cough, together with low persistence with ICS
therapy.5 13 20 A recent Swedish study reported the same
pattern of poor persistence with ICS, although the
authors did not consider liberal ICS prescription by phy-
sicians.21 Although it has been speculated that low ICS
persistence rates could be explained by the use of ICS as
a diagnostic treatment trial in children with non-speciﬁc
respiratory symptoms, previous studies never examined
the reasons for ICS prescription behaviour of GPs.
Our focus group interview with GPs now provides
unique and innovative insights into the pragmatic way in
which GPs deal with the large number of children present-
ing with various respiratory symptoms. In agreement with
our results, previous studies reported that primary care
paediatricians from the USA and Spain recommended
short-course ICS therapy for ﬁctional patients with asthma,
virus-induced wheeze and bronchiolitis.22–24 In these
studies, primary care physicians with limited experience in
respiratory disorders were most likely to show this erratic
prescribing behaviour. Our study indicates that such
limited experience is associated with lack of conﬁdence in
making or excluding a diagnosis of asthma, particularly in
young children, and with non-evidence-based perceptions
about the effects of short-course ICS therapy on cough
and on mild intermittent wheezing, conﬁrming ﬁndings
from a previous study.25
Because establishing the diagnosis of asthma may
indeed be difﬁcult, in particular in young children,26 and
because most respiratory symptoms in young children are
transient, the pragmatic approach of GPs to treat non-
speciﬁc respiratory symptoms with short courses of ICS is
understandable, particularly when considering their view
that short ICS courses are harmless and that they do not
want to undertreat asthma. Nevertheless, there are
numerous reasons to discourage this practice. First, even
though most of these children inappropriately being pre-
scribed ICS used the medication only brieﬂy, some of
these children were unnecessarily exposed to daily ICS
for long periods of time, increasing the risk of exposure
to high doses of ICS and their associated side effects.27
Second, under this regime, children with asthma were
also treated intermittently with ICS instead of the recom-
mended daily use.1–3 Third, inappropriate ICS treatment
may distract from appropriately diagnosing and treating
the real cause of their respiratory symptoms, such as a
lower respiratory tract infection or allergic rhinitis.28
Fourth, prescribing ICS to satisfy parents and to avoid
lengthy discussions about referral or the lack of effective
treatment for cough, although helpful in running an efﬁ-
cient clinic in the short term, may jeopardise a construct-
ive physician–patient–parent relationship in future
consultations. Finally, unnecessary ICS treatment for non-
speciﬁc cough generates considerable societal costs (an
estimated €1 million per annum in our country for 17
million inhabitants).
Our study has considerable implications both for
research and for clinical practice. ICS persistence and
adherence studies are usually based on large pharmacy
databases, with limited information about physician’s
considerations, beliefs and prescribing practices. Such
studies rely heavily on appropriate diagnosing and pre-
scribing behaviour of physicians, while our study illus-
trates how important it is to take the physicians’
prescribing behaviour into account to interpret and
understand these data. The GPs in our study acknowl-
edged the problem of lack of proactively organised
primary care for children with respiratory symptoms,
and suggested using specialised nurses as an important
solution to ensure scheduled follow-up for these
patients. Previous studies from our group have shown
that children with a conﬁrmed diagnosis of asthma can
effectively and cost-efﬁciently be followed up by asthma
nurses.29 The GPs themselves, however, are responsible
for solving the problem of inappropriately prescribing
ICS to children without persistent asthma and advising
short courses of ICS to children with asthma. The pres-
ence of erratic perceptions suggests the need for add-
itional targeted training in asthma diagnosis and
management for GPs. Such training has been shown to
be effective in improving asthma care to children.30
Strengths and limitations
The main strength of this study is that we collected
detailed information about the patients’ symptoms and
ICS use, and on the reasons and motivations for GPs’
prescribing behaviour, which not only highlighted
important areas for improvement in primary care for
children with asthma, but also provided a novel explan-
ation for the previously described poor ICS persistence
in children. The main limitation is the generalisability of
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this study because we studied only the GPs willing to par-
ticipate in the study, a number of whom had shown spe-
ciﬁc interest in childhood asthma care. Because of this
interest of these GPs, it is not likely other GPs perform
better in prescribing ICS and following asthma guide-
lines. Although our study sample of GPs participating in
the follow-up study and those participating in the focus
group study may have been subject to selection bias,
with relative over-representation of middle-aged male
GPs, the striking similarities of our ﬁndings with previ-
ous reports of prescribing patterns of ICS in primary
care in several countries5 7 13 20–24 suggest that our ﬁnd-
ings can be applied to most settings of primary care.
A second limitation is recall bias because parental
report of asthmatic symptoms in their children was
recorded retrospectively, at the end of the follow-up
period. However, because the questionnaire we used for
this purpose was validated and has been used extensively
in previous work, it is unlikely that this had a major
inﬂuence on our ﬁndings.16 19
CONCLUSION
Inappropriate prescription of ICS to children by GPs is
common and is driven by a pragmatic approach to treat
symptoms rather than making or excluding a diagnosis of
asthma, erratic perceptions about the efﬁcacy of ICS in
reducing persistent cough and mild intermittent wheeze,
and a reactive organisation of primary care where sched-
uled follow-up is exceptional. The inappropriate prescrib-
ing behaviour of GPs that we observed drives the lack of
persistence with ICS therapy in primary care and this
ﬁnding should be taken into account when interpreting
data from large prescription database studies. The large
number of inappropriate ICS prescriptions together with
intermittent therapy in children with asthma stresses the
need to improve GPs’ knowledge and competence in diag-
nosing and managing asthma in children in primary care.
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